This activity is expired and is no longer available for CME credit.

EXPERT INTERVIEWTUTORIAL

Rheumatoid Arthritis Disease Activity Measurement: A Comparison of the Sensitivity and Specificity of RAPID3 and CDAI

Author(s)/Faculty: Jeffrey R. Curtis, MD, MPH, MS
Release Date: 5/21/2014Expiration Date: 5/20/2015
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: MonographProvider:
I'm here today to talk about a recently presented randomized control trial that randomized 733 Rheumatoid Arthritis patients that had failed at least one DMARD, or biologic, to management with either the rapid 3 disease activity measurement tool, or the CDAI disease activity tool...